Testing the efficacy of new gene therapies more efficiently

Tuesday, March 21, 2017 - 13:03 in Health & Medicine

Using a new cellular model, innovative gene therapy approaches for the hereditary immunodeficiency Chronic Granulomatous Disease can be tested faster and cost-effectively in the lab for their efficacy. A team of researchers has successfully achieved this using the 'gene-scissor' CRISPR/Cas9 technology. The aim is to treat severely affected patients in the near future using novel approaches.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net